Fructose Metabolism, Inborn Errors

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Fructose Metabolism, Inborn Errors trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06852612

Dietary Treatment Strategies and Metabolic Control in Glycogen Storage Disease Type I

The present project will specifically assess metabolic effects of dietary interventions with controlled intake of fructose and fructose/galactose in GSDI, with…

Switzerland20 participantsStarted 2025-04-24

Treatment: Fructose, Fructose and galactose

All recent trials (21 shown)

Not Yet RecruitingNot Applicable

NCT07337707

New Microbiota-endocrine Axis in Fructose Malabsorption-caused Visceral Hypersensitivity in Irritable Bowel Syndrome.

Irritable bowel syndrome (IBS) affects around 4% of the general population and remains the most common functional bowel disorder. It is defined by the Rome crit…

France60 participantsStarted 2026-02

Treatment: urine intestinal permeability test or lactulose/mannitol test, Blood test

CompletedNot Applicable

NCT05687474

Baby Detect : Genomic Newborn Screening

Newborn screening (NBS) is a global initiative of systematic testing at birth to identify babies with pre-defined severe but treatable conditions. With a simple…

Belgium6,824 participantsStarted 2022-09-01

Fructose Metabolism, Inborn Errors

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Dietary Treatment Strategies and Metabolic Control in Glycogen Storage Disease Type I

All recent trials (21 shown)

New Microbiota-endocrine Axis in Fructose Malabsorption-caused Visceral Hypersensitivity in Irritable Bowel Syndrome.

Baby Detect : Genomic Newborn Screening

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Dietary Treatment Strategies and Metabolic Control in Glycogen Storage Disease Type I

All recent trials (21 shown)

New Microbiota-endocrine Axis in Fructose Malabsorption-caused Visceral Hypersensitivity in Irritable Bowel Syndrome.

Baby Detect : Genomic Newborn Screening

Early Check: Expanded Screening in Newborns

Observational Study on the Safety and Efficacy of the Medical Product Fructosin.

Biomarker for Glycogen Storage Diseases (BioGlycogen)

Investigation of Alanine in Fructose Intolerance: A Dose Ranging Study

Fructose and Lactose Intolerance and Malabsorption in Functional Gastrointestinal Disorders

Meta-analyses of the Effect of Important Food Sources of Sugars on Cardiometabolic Risk Factors

Investigation of Supplemental L-alanine in the Management of Dietary Fructose Intolerance

Clinical Utility of Breath Tests in GI

Metabolic Consequences of Heterozygous Hereditary Fructose Intolerance

Fructose Supplementation in Carriers for Hereditary Fructose Intolerance

Is the Expression of the GLUT5 Specific Fructose Transport Protein Abnormal in Patients With Fructose Intolerance?

Effects of Exercise on Fructose-induced Postprandial Lipemia

Meta-analyses of Impotrant Food Sources of Sugars and Incident Cardiometabolic Diseases

Fructose Malabsorption in Northern Norway

Meta-analyses of the Effect of Sucrose Versus High Fructose Corn Syrup on Cardiometabolic Risk

Meta-analyses of Total and Individual Fructose-containing Sugars and Incident Cardiometabolic Disease

Meta-analyses of Fructose and Cardiometabolic Risk

Efficacy of Fructose Metabolizing Enzymatic Product in Fructose Malabsorption